Research graph
References from Treatment-related neuroanatomical and functional consequences of hematopoietic stem cell transplantation: A comprehensive review of brain structure and function. Local targets link to admitted publications; unresolved targets remain external evidence.
Immune escape after hematopoietic stem cell transplantation (HSCT): From mechanisms to novel therapies
10.3390/cancers12010069 · 2019 · External reference
Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD
10.1038/s41571-020-0356-4 · 2020 · External reference
CNS-targeting therapies for lysosomal storage diseases: Current advances and challenges
10.3389/fmolb.2020.559804 · 2020 · External reference
A review of acute and long-term neurological complications following haematopoietic stem cell transplant for paediatric acute lymphoblastic leukaemia
10.3389/fped.2021.774853 · 2021 · External reference
Stem cell transplantation therapy and neurological disorders: Current status and future perspectives
2022 · External reference
Noninfectious neurologic complications after allogeneic hematopoietic stem cell transplantation
10.1016/j.bbmt.2019.05.024 · 2019 · External reference
High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease
10.1038/s41409-018-0293-3 · 2019 · External reference
Strengths and challenges of longitudinal non-human primate neuroimaging
10.1016/j.neuroimage.2021.118009 · 2021 · External reference
Mental status changes after hematopoietic stem cell transplantation
10.1002/cncr.24496 · 2009 · External reference
Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature
10.1186/s13244-024-01605-y · 2024 · External reference
Improved brain pathology and progressive peripheral neuropathy in a 15 year old survivor of infantile krabbe disease treated with umbilical cord transplantation
10.3389/fnmol.2022.888231 · 2022 · External reference
Advances in therapies for neurological lysosomal storage disorders
10.1002/jimd.12615 · 2023 · External reference
Mucopolysaccharidosis IVA: Diagnosis, treatment, and management
10.3390/ijms21041517 · 2020 · External reference
Stem cell therapy for post-traumatic stress disorder: A novel therapeutic approach
10.3390/diseases9040077 · 2021 · External reference
Induced pluripotent stem cell-derived neural progenitor cell transplantation promotes regeneration and functional recovery after post-traumatic stress disorder in rats
10.1016/j.biopha.2020.110981 · 2021 · External reference
Associations between executive functioning, personality, and posttraumatic stress symptoms in adolescent solid organ transplant recipients
10.1111/petr.14176 · 2022 · External reference
Neurocognitive impairment after hematopoietic stem cell transplant for hematologic malignancies: phenotype and mechanisms
10.1002/onco.13867 · 2021 · External reference
Recent Topics on The mechanisms of immunosuppressive therapy-related neurotoxicities
10.3390/ijms20133210 · 2019 · External reference
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study
10.1038/s41591-022-02097-3 · 2023 · External reference
Depicting the anatomy of the gyral white matter: ubi sumus? quo vadimus
10.1093/braincomms/fcad265 · 2023 · External reference
Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients
10.1038/s41409-021-01365-z · 2021 · External reference
Neuroimaging and psychometric assessment of mild cognitive impairment after traumatic brain injury
10.3389/fpsyg.2020.01423 · 2020 · External reference
Tractography-based analysis of morphological and anatomical characteristics of the uncinate fasciculus in human brains
10.3390/brainsci10100709 · 2020 · External reference
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells
10.1038/s41571-020-00456-y · 2021 · External reference
White matter abnormalities in paediatric obsessive-compulsive disorder: a systematic review of diffusion tensor imaging studies
10.1007/s11682-023-00761-x · 2023 · External reference
Autologous hematopoietic stem cell transplantation in multiple sclerosis patients: Monocentric case series and systematic review of the literature
10.3390/jcm11040942 · 2022 · External reference
Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis
10.1002/ajh.27297 · 2024 · External reference
Rehabilitation before and after autologous haematopoietic stem cell transplantation (ahsct) for patients with multiple sclerosis (ms): consensus guidelines and recommendations for best clinical practice on behalf of the autoimmune diseases working party, nurses group, and patient advocacy committee of the european society for blood and marrow transplantation (ebmt)
10.3389/fneur.2020.556141 · 2020 · External reference
Neurocognitive functioning in long-term survivors of pediatric hematopoietic cell transplantation
10.1038/s41409-020-01125-5 · 2021 · External reference
Cognitive functioning in survivors of hematopoietic stem cell transplantation compared with a matched general population sample-the maastricht observational study of late effects after stem cell transplantation study
10.1016/j.jtct.2023.03.026 · 2023 · External reference
Long term disease burden post-transplantation: Three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)
10.1186/s13023-020-01644-w · 2021 · External reference
Abstracts of the 5th sfcns congress—swiss federation of clinical neuro-societies basel, Switzerland, September 28–30, 2022
10.3390/ctn6030022 · 2022 · External reference
Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation
2021 · External reference
Cognitive complaints by hematopoietic cell transplantation recipients and change in neuropsychological performance over time
2021 · External reference
French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases
10.1016/j.revmed.2023.12.008 · 2024 · External reference
Survival protection of patients undergoing hematopoietic stem cell transplantation: grounded theory
2023 · External reference
Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT
10.1038/s41409-021-01539-9 · 2022 · External reference
Hematopoietic stem cell factors: their functional role in self-renewal and clinical aspects
10.3389/fcell.2022.664261 · 2022 · External reference
Stiff-person syndrome and gad antibody-spectrum disorders: gabaergic neuronal excitability, immunopathogenesis and update on antibody therapies
10.1007/s13311-022-01188-w · 2022 · External reference
Transcranial magnetic stimulation as a diagnostic and therapeutic tool in various types of dementia
10.3390/jcm10132875 · 2021 · External reference
Neurological complications in Chinese children undergoing hematopoietic stem cell transplantation
10.1007/s00381-021-05235-3 · 2021 · External reference
Neurotoxicidades apresentadas por pacientes submetidos ao transplante de células-tronco hematopoéticas: Uma revisão de escopo
10.37689/acta-ape/2022ar000567 · 2022 · External reference
Hematopoietic stem cell transplantation for neurological disorders: a focus on inborn errors of metabolism
10.3389/fncel.2022.895511 · 2022 · External reference
Total body irradiation for hematopoietic stem cell transplantation: What can we agree on
10.3390/curroncol28010089 · 2021 · External reference
Long-term follow-up of hematopoietic stem cell transplant survivors: a focus on screening, monitoring, and therapeutics
10.1002/phar.2443 · 2020 · External reference
Impact of cancer treatment on cognitive function: a systematic review of data in hematological malignancies
2020 · External reference
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL-long-term follow-up from the prospective ALL-SCT 2003 trial
10.1038/s41375-022-01693-z · 2022 · External reference
New insight into neurological degeneration: Inflammatory cytokines and blood-brain barrier
10.3389/fnmol.2022.1013933 · 2022 · External reference
Oxidative stress, mitochondrial dysfunction, and aging
10.1155/2012/646354 · 2012 · External reference
Targeting the BDNF/TrkB pathway for the treatment of tumors
2019 · External reference
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
10.1186/s13046-021-02148-6 · 2021 · External reference
Challenges and opportunities of translating animal research into human trials in Ethiopia
10.1186/s12874-024-02338-8 · 2024 · External reference
Biobehavioral research and hematopoietic stem cell transplantation: expert review from the biobehavioral research special interest group of the american society for transplantation and cellular therapy
10.1016/j.jtct.2021.06.007 · 2021 · External reference
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system
10.1016/j.ijrobp.2009.12.061 · 2011 · External reference
Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis
10.1007/s11060-024-04650-1 · 2024 · External reference
Taking thalidomide out of rehab
10.1038/nm0410-370 · 2010 · External reference
A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury
10.1126/scitranslmed.abm6543 · 2023 · External reference
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: A randomized, double-blind, placebo-controlled trial
10.1093/neuonc/not114 · 2013 · External reference
Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8+ T lymphocytes
10.1016/j.neuron.2022.12.009 · 2023 · External reference
Immune-mediated disruption of the blood-brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets
10.1111/cns.14853 · 2024 · External reference
The central nervous system is a target of acute graft versus host disease in mice
10.1182/blood-2012-09-456590 · 2013 · External reference
Analysis of cerebrospinal fluid chimerism after hematopoietic stem cell transplantation: Case report
10.1016/j.htct.2024.04.129 · 2024 · External reference
Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation
10.1038/s41409-019-0532-2 · 2020 · External reference
Temporal evolution of functional immune reconstitution after allogeneic hsct
10.1016/j.jtct.2025.03.001 · 2025 · External reference
Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation
10.1038/s41375-023-01840-0 · 2023 · External reference
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: A 2023 update
10.1016/j.jtct.2023.12.001 · 2024 · External reference
Neuropsychological outcomes following HSCT in MS: A systematic review
10.1016/j.msard.2024.105702 · 2024 · External reference
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial
10.3389/fneur.2024.1263373 · 2024 · External reference
Monitoring neurocognitive functioning after pediatric cellular therapy or hematopoietic cell transplant: Guidelines from the cog neurocognition in cellular therapies task force
10.1016/j.jtct.2022.06.027 · 2022 · External reference
Total body irradiation in haematopoietic stem cell transplantation: a comprehensive literature review and institutional experience from the policlinico of catania
10.3390/medicina61091503 · 2025 · External reference
Human leukocyte antigen-haploidentical haematopoietic stem cell transplantation using post-transplant cyclophosphamide for paediatric haematological malignancies
10.3390/cancers16030600 · 2024 · External reference
Early and late toxicities of chimeric antigen receptor t-cells
10.1016/j.hoc.2023.05.010 · 2023 · External reference
Total body irradiation in haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia: Review of the literature and future directions
10.3389/fped.2021.774348 · 2021 · External reference
Long-term neurocognitive and quality of life outcomes in survivors of pediatric hematopoietic cell transplant
10.1007/s11764-021-01063-1 · 2022 · External reference
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT
10.1038/s41582-024-01050-x · 2025 · External reference
Growth in the face of overwhelming pressure: A narrative review of sibling donor experiences in pediatric hematopoietic stem cell transplant
10.1177/13674935211043680 · 2023 · External reference
Change of white matter integrity in children with hematopoietic stem cell transplantation
10.1016/j.pediatrneurol.2020.06.008 · 2020 · External reference
Impact of adequate day 30 post-pediatric hematopoietic stem cell transplantation vitamin d level on clinical outcome: An observational cohort study
10.1016/j.jtct.2022.05.032 · 2022 · External reference
Long-term brain status and cognitive impairment in children treated for high-risk acute lymphoblastic leukemia with and without allogeneic hematopoietic stem cell transplantation: A single-center study
10.1002/pbc.28224 · 2020 · External reference
Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease
10.1182/blood.2022016618 · 2023 · External reference
The prospective effects of coping strategies on mental health and resilience at five months after hsct
10.3390/healthcare11131975 · 2023 · External reference
Stress and coping strategies among allogeneic haematopoietic stem cell transplantation survivors: A qualitative study
2020 · External reference
Quality of life, physical functioning, and psychological distress of older adults undergoing hematopoietic stem cell transplantation
10.1016/j.jtct.2023.03.017 · 2023 · External reference
CNS manifestations in acute and chronic graft-versus-host disease
10.1093/brain/awae340 · 2025 · External reference
A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients
10.1007/s11682-013-9221-8 · 2013 · External reference
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation
10.1186/s13014-022-02161-9 · 2022 · External reference
Fatigue as mediator factor in ptsd-symptoms after allogeneic hematopoietic stem cell transplantation
10.3390/jcm12082756 · 2023 · External reference
Anxiety, depression, and mental health-related quality of life in survivors of pediatric allogeneic hematopoietic stem cell transplantation: a systematic review
10.1038/s41409-020-0782-z · 2020 · External reference
Viral encephalitis after hematopoietic cell transplantation: A systematic review
10.1016/j.jtct.2023.06.022 · 2023 · External reference
Response and toxicity to cytarabine therapy in leukemia and lymphoma: from dose puzzle to pharmacogenomic biomarkers
10.3390/cancers13050966 · 2021 · External reference
Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation
10.1038/sj.bmt.1704688 · 2004 · External reference
The contribution of thymic tolerance to central nervous system autoimmunity
10.1007/s00281-020-00822-z · 2021 · External reference
Epileptic seizures after allogeneic hematopoietic stem cell transplantation
2021 · External reference
Haematopoietic stem cell transplantation for the treatment of multiple sclerosis: Recent advances
10.1007/s11910-023-01290-2 · 2023 · External reference
Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation
10.1038/s41598-021-87989-z · 2021 · External reference
Common sources of inflammation and their impact on hematopoietic stem cell biology
10.1007/s40778-020-00177-z · 2020 · External reference
Inflammatory mediators and GBM malignancy: Current scenario and future prospective
10.24976/discov.med.202335177.47 · 2023 · External reference
Th17 cells and inflammation in neurological disorders: Possible mechanisms of action
2022 · External reference
Preconditioning strategies to enhance neural stem cell-based therapy for ischemic stroke
10.3390/brainsci10110893 · 2020 · External reference
Recent advances in stem cell therapies to address neuroinflammation, stem cell survival, and the need for rehabilitative therapies to treat traumatic brain injuries
10.3390/ijms22041978 · 2021 · External reference
Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients
10.1186/s12887-021-02890-y · 2021 · External reference
The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis
10.3389/fneur.2024.1385042 · 2024 · External reference
The therapeutic mechanisms of mesenchymal stem cells in ms-a review focusing on neuroprotective properties
10.3390/ijms25031365 · 2024 · External reference
Neuroprotective therapies in the NICU in term infants: present and future
10.1038/s41390-022-02295-2 · 2023 · External reference
Impact of cognitive rehabilitation on cognitive and functional outcomes in adult cancer survivors: A systematic review
10.1016/j.soncn.2024.151696 · 2024 · External reference
Patients´ experiences and perspectives of challenges and needs related to nonmyeloablative stem cell transplantation: Involving patients in developing a targeted rehabilitation programme
10.1111/jocn.14739 · 2019 · External reference
The role of physical rehabilitation in stem cell transplantation patients
2015 · External reference
Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
10.1182/bloodadvances.2022009632 · 2023 · External reference
Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study)
10.1136/bmjopen-2022-068480 · 2023 · External reference
The management of pain during pediatric hematopoietic stem cell transplantation: A qualitative study of contextual factors that influenced pain management practices
10.1002/pbc.30614 · 2023 · External reference
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy
10.1002/acn3.51796 · 2023 · External reference
Breaking barriers: Supporting hematopoietic stem cell transplant program through collaborative radiation therapy service from a physically distant center
10.1186/s43046-024-00221-7 · 2024 · External reference
Cost Effectiveness of Hematopoietic Stem Cell Transplantation Compared with Transfusion Chelation for Treatment of Thalassemia Major
10.1016/j.bbmt.2018.04.005 · 2018 · External reference
Concise Review: The high cost of high tech medicine: Planning ahead for market access
10.1002/sctm.16-0487 · 2017 · External reference
Sexual dimorphism in immune cell responses following stroke
10.1016/j.nbd.2022.105836 · 2022 · External reference
Gender and the length of time since autologous hematopoietic stem cell transplantation-What is their influence on the immune reconstitution in multiple myeloma patients
10.1371/journal.pone.0295308 · 2023 · External reference
Persistent impairment in immune reconstitution and worse survival outcomes in allogeneic stem cell transplantation patients with early coronavirus disease 2019 infection
10.1016/j.jtct.2024.04.021 · 2024 · External reference
New autoimmune disorder development after immune reconstitution therapy for multiple sclerosis
10.1038/s41598-024-82196-y · 2024 · External reference
